BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 32448281)

  • 1. TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity.
    Wang X; Wang Q; Li W; Zhang Q; Jiang Y; Guo D; Sun X; Lu W; Li C; Wang Y
    J Exp Clin Cancer Res; 2020 May; 39(1):93. PubMed ID: 32448281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrotanshinone exhibits an anti-inflammatory effect in vitro and in vivo through blocking TLR4 dimerization.
    Yuan R; Huang L; Du LJ; Feng JF; Li J; Luo YY; Xu QM; Yang SL; Gao H; Feng YL
    Pharmacol Res; 2019 Apr; 142():102-114. PubMed ID: 30794925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elabela ameliorates doxorubicin-induced cardiotoxicity by promoting autophagic flux through TFEB pathway.
    Chen D; Yu W; Zhong C; Hong Q; Huang G; Que D; Wang Y; Yang Y; Rui B; Zhuang Z; Liang M; Ye Z; Yan X; Lv J; Zhang R; Yan J; Yang P
    Pharmacol Res; 2022 Apr; 178():106186. PubMed ID: 35306141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic Acid Attenuates Doxorubicin-induced Cytotoxicity and Inflammation by Suppressing NF-κB/iNOS/NO Signaling Pathway Activation in H9C2 Cardiac Cells.
    Wang ZQ; Chen MT; Zhang R; Zhang Y; Li W; Li YG
    J Cardiovasc Pharmacol; 2016 Apr; 67(4):283-9. PubMed ID: 26657886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
    Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
    Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity.
    Li X; Liang J; Qin A; Wang T; Liu S; Li W; Yuan C; Qu L; Zou W
    J Ethnopharmacol; 2022 Apr; 287():114943. PubMed ID: 34954266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
    Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
    Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-induced apoptosis in H9c2 cardiomyocytes by NF-κB dependent PUMA upregulation.
    Li D; Li J; An Y; Yang Y; Zhang SQ
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2323-9. PubMed ID: 24065225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
    Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
    Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
    Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
    Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of TNF-α-induced NF-κB signaling pathway and anti-cancer therapeutic response of dihydrotanshinone I.
    Wang F; Ma J; Wang KS; Mi C; Lee JJ; Jin X
    Int Immunopharmacol; 2015 Sep; 28(1):764-72. PubMed ID: 26283590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.
    Dhingra R; Guberman M; Rabinovich-Nikitin I; Gerstein J; Margulets V; Gang H; Madden N; Thliveris J; Kirshenbaum LA
    Cardiovasc Res; 2020 May; 116(6):1161-1174. PubMed ID: 31566215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity.
    Ozcan M; Guo Z; Valenzuela Ripoll C; Diab A; Picataggi A; Rawnsley D; Lotfinaghsh A; Bergom C; Szymanski J; Hwang D; Asnani A; Kosiborod M; Zheng J; Hayashi RJ; Woodard PK; Kovacs A; Margulies KB; Schilling J; Razani B; Diwan A; Javaheri A
    Cell Metab; 2023 Jun; 35(6):928-942.e4. PubMed ID: 36868222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol extracts of Rhaponticum uniflorum (L.) DC flowers attenuate doxorubicin-induced cardiotoxicity via alleviating apoptosis and regulating mitochondrial dynamics in H9c2 cells.
    Hu B; Zhen D; Bai M; Xuan T; Wang Y; Liu M; Yu L; Bai D; Fu D; Wei C
    J Ethnopharmacol; 2022 Apr; 288():114936. PubMed ID: 35007682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ozone Attenuated H9c2 Cell Injury Induced by Doxorubicin.
    Xu L; Wang C; Zou Z; Wu Z
    J Cardiovasc Pharmacol; 2021 Jul; 78(1):e86-e93. PubMed ID: 33929391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocin protects against cardiotoxicity induced by doxorubicin through TLR-2/NF-κB signal pathway in vivo and vitro.
    Chu X; Zhang Y; Xue Y; Li Z; Shi J; Wang H; Chu L
    Int Immunopharmacol; 2020 Jul; 84():106548. PubMed ID: 32388215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways.
    El-Ela SRA; Zaghloul RA; Eissa LA
    Nutrition; 2022 Oct; 102():111732. PubMed ID: 35816809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy.
    Bartlett JJ; Trivedi PC; Yeung P; Kienesberger PC; Pulinilkunnil T
    Biochem J; 2016 Nov; 473(21):3769-3789. PubMed ID: 27487838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.